Notable Downgrades: Citigroup (C), Allergan (AGN), DR Horton (DHI), NetApp (NTAP)

Analysts at Keefe Bruyette downgraded Citigroup Inc. (C) from ‘Outperform’ to ‘Market Perform’ in a research report issued to clients on Monday. The firm said Citi’s most recent quarterly beat was of “low quality” and that shares are fairly valued. On valuation measures, Citigroup Inc. stock it’s trading at a forward P/E multiple of 8.19x, […] View the full post at: Notable Downgrades: Citigroup (C), Allergan (AGN), DR Horton (DHI), NetApp (NTAP) Related posts: Allergan Gets FDA Approval: Botox Has a Medical Use?! NetApp Reluctant to Give Guidance What’s Up with Citigroup?